Abstract
Surgical oophorectomy and orchiectomy, first proposed over a century ago, are effective in thetherapy of breast and prostate cancer, respectively. Later, the discovery of steroid hormones and the steroidhormone receptors led to the concept that inhibition of steroid hormone receptor function by an antagonistprevents tumour growth. While the first anti-hormones, cyproterone acetate (CPA) and tamoxifen, were foundaccidentally, a deeper understanding of steroid hormone receptors as transcription factors enabledmore rational, structure–activity relationship-based drug discovery programmes. This review willprovide both a background on principles and an update on recent developments in the field of endocrinetherapy of cancer.
Results from recent drug-finding programmes on new steroid hormone receptor antagonists will be reviewed.Among these, new steroidal and non-steroidal compounds with increased potency and efficacy, improved tissueselectivity, and without any agonistic activity will be described. New pre-clinical and clinical data ondevelopment candidates will be reported. Advanced breast and prostate cancer is effectively managed byestrogen and androgen ablation, respectively. However, although steroid hormone receptors– estrogenreceptor α (ERα) and androgen receptor (AR) – are still functionally expressed, this therapyfails in a majority of cases. As a novel strategy for the treatment of advanced breast and prostatecancer, the selective down-regulation of the receptor (ER or AR, respectively) has been proposed and thisnew therapeutic concept provides a significant inhibition of tumour growth in vivo.
In addition, it will be our intention to present a deeper insight into the biosynthesis of steroidhormones, which will allow definition of new targets and approaches for the treatment of endocrine-responsivecancer. Enzymes involved in mechanisms of steroid hormone biosynthesis might be novel targets for endocrinetherapy. Moreover, further therapeutic indications for modulators of steroid hormone receptors will bediscussed. In summary, many promising new opportunities for endocrine therapy of breast and prostate cancerare now arising.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Abbreviations
- AACR:
-
American Association for Cancer Research
- AF-1/-2:
-
Activation function 1 or 2
- AI:
-
Aromatase inhibitor
- AR:
-
Androgen receptor
- ARE:
-
Androgen response element
- BPH:
-
Benign prostate hyperplasia
- CIS:
-
Carcinoma in situ
- CPA:
-
Cyproterone acetate
- CR:
-
Complete response
- DBD:
-
DNA binding domain
- DES:
-
Diethylstilbestrol
- DHEA:
-
Dehydoepiandrostenedione
- DHT:
-
Dihydrotestosterone
- E1:
-
Estrone
- E1S:
-
Estrone sulfate
- E2:
-
17β-Estradiol
- EGF:
-
Epidermal growth factor
- EGFR:
-
Epidermal growth factor receptor
- EORTC:
-
European Organisation for Research and Treatment of Cancer
- ER:
-
Estrogen receptor
- ERE:
-
Estrogen response element
- ERKO:
-
Estrogen receptor knock-out mouse
- FSH:
-
Follicle-stimulating hormone
- GnRH:
-
Gonadotropin-releasing hormone
- GR:
-
Glucocorticoid receptor
- HRE:
-
Hormone response element
- HSD:
-
17β-Hydroxysteroid dehydrogenase
- HSP:
-
Heat shock protein
- IEN:
-
Intraepithelial neoplasia
- IGF-1:
-
Insulin-like growth factor 1
- IL-6:
-
Interleukin 6
- KGF:
-
Keratinocyte growth factor
- LBD:
-
Ligand-binding domain
- LH:
-
Luteinising hormone
- LHRH:
-
Luteinising hormone releasing hormone
- MAPK:
-
Mitogen-activated protein kinase
- MGA:
-
Megestrol acetate
- MPA:
-
Medroxyprogesterone acetate
- MMTV:
-
Murine mammary tumour virus
- MR:
-
Mineralocorticoid receptor
- NCI:
-
National Cancer Institute
- 4-OHA:
-
4-Hydroxyandrostendione
- 4-OHT:
-
4-Hydroxytamoxifen
- OR:
-
Objective response
- PIN:
-
Prostate intraepithelial neoplasia
- PR:
-
Progesterone receptor
- PR:
-
Partial response
- PRE:
-
Progesterone response element
- PRKO:
-
Progesterone receptor knock-out mouse
- PSA:
-
Prostate-specific antigen
- RAR/RXR:
-
Retinoic acid receptors
- USPSTF:
-
US Preventive Services Task Force
- SD:
-
Stable disease
- SERD:
-
Selective estrogen receptor destabiliser
- SERM:
-
Selective estrogen receptor modulator
- SRC:
-
Steroid receptor co-activator
- STS:
-
Steroid sulfatase
- TR:
-
Thyroid hormone receptor
References
Florio S, Pagnini U, Crispino A, Pacilio C, Crispino L, Giordano A (2002) Front Biosci 7:1590
Ortmann O, Diedrich K (1999) Hum Reprod 14:194
Burger HG, Dudley E, Mamers P, Robertson D, Groome N, Dennerstein L (2002) Novartis Found Symp 242:161
Piltonen T, Koivunen R, Morin-Papunen L, Ruokonen A, Huhtaniemi IT, Tapanainen JS (2002) Hum Reprod 17:620
Smith CL, O'Malley BW (2004) Endocr Rev 25:45
Ariazi EA, Jordan VC (2006) Curr Top Med Chem 6:181
Tirona RG, Kim RB (2005) J Pharm Sci 94:1169
Fu M, Wang C, Zhang X, Pestell RG (2004) Biochem Pharmacol 68:1199
Reid G, Denger S, Kos M, Gannon F (2002) Cell Mol Life Sci 59:821
Metivier R, Reid G, Gannon F (2006) EMBO Rep 7:161
Hewitt SC, Harrell JC, Korach KS (2005) Annu Rev Physiol 67:285
Butt AJ, McNeil CM, Musgrove EA, Sutherland RL (2005) Endocr Relat Cancer S1:S47
Nettles KW, Greene GL (2005) Ann Rev Physiol 67:309
Glass CK (1994) Endocr Rev 15:391
Klinge CM (2001) Nucleic Acids Res 29:2905
Harrington WR, Sheng S, Barnett DH, Petz LN (2003) Mol Cell Endocrinol 206:13
Couse JF, Korach KS (1999) Estrogen Endocrine Rev 20:358
Ramsey TL, Risinger KE, Jernigan SC, Mattingly KA, Klinge CM (2004) Endocrinology 145:149
Pike AC, Brzozowski AM, Hubbard RE, Bonn T, Thorsell AG, Engstrom O, Ljunggren J, Gustafsson J-Å, Carlquist M (1999) EMBO J 18:4608
Shiau AK, Barstad D, Loria PM, Cheng L, Kushner PJ, Agard DA, Greene GL (1998) Cell 95:927
Shiau AK, Barstad D, Radek JT, Meyers MJ, Nettles KW, Katzenellenbogen BS, Katzenellenbogen JA, Agard DA, Greene GL (2002) Nat Struct Biol 9:359
Lavinsky RM, Jepsen K, Heinzel T, Torchia J, Mullen TM, Schiff R, Del-Rio AL, Ricote M, Ngo S, Gemsch J, Hilsenbeck SG, Osborne CK, Glass CK, Rosenfeld MG, Rose DW (1998) Proc Natl Acad Sci USA 95:2920
Conneely OM, Lydon JP, De Mayo F, O'Malley BW (2000) J Soc Gynecol Investig 7:S25
Williams SP, Sigler PB (1998) Nature 393:392
Lydon JP, DeMayo FJ, Funk CR, Mani SK, Hughes AR, Montgomery CA Jr, Shyamala G, Conneely OM, O'Malley BW (1995) Genes Dev 15:2266
Chappell PE, Lydon JP, Conneely OM, O'Malley BW, Levine JE (1997) Endocrinology 138:4147
Conneely OM, Jericevic BM, Lydon JP (2003) J Mammary Gland Biol Neoplasia 8:205
Humphreys RC, Lydon J, O'Malley BW, Rosen JM (1997) Mol Endocrinol 11:801
Brisken C, Park S, Vass T, Lydon JP, O'Malley BW, Weinberg RA (1998) Proc Natl Acad Sci USA 95:5076
Kurita T, Young P, Brody JR, Lydon JP, O'Malley BW, Cunha GR (1998) Endocrinology 139:4708
Lydon JP, Ge G, Kittrell FS, Medina D, O'Malley BW (1999) Cancer Res 59:4276
Musgrove EA, Lee CS, Cornish AL, Swarbrick A, Sutherland RL (1997) Mol Endocrinol 11:54
Lange CA, Richer JK, Shen T, Horwitz KB (1998) J Biol Chem 273:31308
Groshong SD, Owen GI, Grimison B, Schauer IE, Todd MC, Langan TA, Sclafani RA, Lange CA, Horwitz KB (1997) Mol Endocrinology 11:1593
Sarup JC, Rao KVS, Fox CF (1988) Cancer Res 48:5071
Lange CA, Richer JK, Horwitz KB (1999) Mol Endocrinol 6:829
Gelmann EP (2002) J Clin Oncol 20:3001
Matias PM, Donner P, Coelho R, Thomaz M, Peixoto C, Macedo S, Otto N, Joschko S, Scholz P, Wegg A, Basler S, Schaefer M, Egner U, Carrodono MA (2000) J Biol Chem 275:26164
Sommer A, Haendler B (2003) Curr Opin Drug Disc Dev 6:702
Brinkmann AO, Blok KL J, De Ruiter PE, Doesburg GP, Stekette K, Berrevoets CA, Trapman J (1999) Steroid Biochem Mol Biol 69:307
Poukka H, Karvonen U, Jaenne OA, Palvimo JJ (2000) Proc Natl Acad Sci USA 97:14145
Feldman BJ, Feldman D (2001) Nat Rev Cancer 1:34
Matias PM, Carrondo MA, Coelho R, Thomaz M, Zhao XY, Wegg A, Crusius K, Egner U, Donner P (2002) J Med Chem 45:1439
Sack JS, Kish KF, Wang C, Attar RM, Kiefer SE, An Y, Wu GY, Scheffler JE, Salvati ME, Krystek SR Jr, Weinmann R, Einspahr HM (2001) Proc Natl Acad Sci USA 98:4904
Brinkmann AO (2001) Mol Cell Endocrinol 179:105
Perissi V, Rosenfeld MG (2005) Nat Rev Mol Cell Biol 6:542
Gronemeyer H, Gustafsson JA, Laudet V (2004) Nat Rev Drug Discov 3:950
Liao L, Kuang SQ, Yuan Y, Gonzalez SM, O'Malley BW, Xu J (2002) Steroid Biochem Mol Biol 83:3
Kumar R, Wang RA, Barnes CJ (2004) Mol Carcinog 41:221
Kumar V, Carlson JE, Ohgi KA, Edwards TA, Rose DW, Escalante CR, Rosenfeld MG, Aggarwal AK (2002) Mol Cell 10:857
Gao X, Loggie BW, Nawaz Z (2002) Mol Cancer 1:7
Lavinsky RM, Jepsen K, Heinzel T, Torchia J, Mullen TM, Schiff R, Del-Rio AL, Ricote M, Ngo S, Gemsch J, Hilsenbeck SG, Osborne CK, Glass CK, Rosenfeld MG, Rose DW (1998) Proc Natl Acad Sci USA 95:2920
Yoon HG, Chan DW, Huang ZQ, Li J, Fondell JD, Qin J, Wong J (2003) EMBO J 22:1336
Hall JM, Chang CY, McDonnell DP (2000) Mol Endocrinol 14:2010
Rodriguez AL, Tamrazi A, Collins ML, Katzenellenbogen JA (2004) J Med Chem 47:600
Berger SL (2001) Oncogene 20:3007
Strahl BD, Allis CD (2000) Nature 403:41
Cheung E, Schwabish MA, Kraus WL (2003) EMBO J 22:600
Acevedo ML, Kraus WL (2003) Mol Cell Biol 23:335
Lösel R, Wehling M (2003) Nat Rev Mol Cell Biol 4:46
Govind AP, Thampan RV (2003) Mol Cell Biochem 253:233
Evinger AJ 3rd, Levin ER (2005) Steroids 70:361
Santen RJ, Song RX, Zhang Z, Kumar R, Jeng MH, Masamura S, Lawrence J Jr, MacMahon LP, Yue W, Berstein L (2005) J Steroid Biochem Mol Biol 95:155–165
Boonyaratanakornkit V, Edwards DP (2004) Essays Biochem 40:105
Filardo EJ, Quinn JA, Frackelton AR Jr, Bland KI (2002) Mol Endocrinol 16:70
Revankar CM, Cimino DF, Sklar LA, Arterburn JB, Prossnitz ER (2005) Science 307:1625
Thomas P, Pang Y, Filardo EJ, Dong J (2005) Endocrinology 146:624
Feng Y, Gregor P (1997) Biochem Biophys Res Commun 231:65
Owman C, Blay P, Nilsson C, Lolait SJ (1996) Biochem Biophys Res Commun 228:285
Carmeci C, Thompson DA, Ring HZ, Francke U, Weigel RJ (1997) Genomics 45:607
Martin LA, Farmer I, Johnston SR, Ali S, Dowsett M (2005) Endocr Relat Cancer 12:75
Dowsett M, Folkerd E, Doody D, Haynes B (2005) Breast 14:452
Brueggemeier RW, Hackett JC, Diaz-Cruz ES (2005) Endocr Rev 26:331
Smith IE, Dowsett M (2003) N Engl J Med 348:2431
Wouters W, Snoeck E, De Coster R (1994) Breast Cancer Res Treat 30:89
Plourde PV, Dyroff M, Dukes M (1994) Breast Cancer Res Treat 30:103
Demers LM (1994) Breast Cancer Res Treat 30:95
Nishino Y, Schneider MR, Michna H, el Etreby MF (1989) J Steroid Biochem 34:435
Pouget C, Fagnere C, Basly JP, Besson AE, Champavier Y, Habrioux G, Chulia AJ (2002) Pharm Res 19:286
Wood PM, Woo LW, Humphreys A, Chander SK, Purohit A, Reed MJ, Potter BV (2005) J Steroid Biochem Mol Biol 94:123
Reed MJ, Purohit A, Woo LW, Newman SP, Potter BV (2005) Endocr Rev 26:171
Goss PE (2003) Am J Clin Oncol 26:27
Howell A, Cuzick J, Baum M, Buzdar A, Dowsett M, Forbes JF, Hoctin-Boes G, Houghton J, Locker GY, Tobias JS, ATAC Trialists' Group (2005) Lancet 365:60
Jones SE (2006) Clin Breast Cancer 6(Suppl 2):41
Thurlimann B, Keshaviah A, Coates AS, Mouridsen H, Mauriac L, Forbes JF, Paridaens R, Castiglione-Gertsch M, Gelber RD, Rabaglio M, Smith I, Wardly A, Price KN, Goldhirsch A, Breast International Group (BIG) 1-98 Collaborative Group (2005) N Engl J Med 353:2747
Ingle JN, Tu D, Pater JL, Martino S, Robert NJ, Muss HB, Piccart MJ, Castiglione M, Shepherd LE, Pritchard KI, Livingston RB, Davidson NE, Norton L, Perez EA, Abrams JS, Cameron DA, Palmer MJ, Goss PE (2006) Breast Cancer Res Treat 99(3):295 (Epub ahead of print)
Goss PE, Ingle JN, Martino S, Robert NJ, Muss HB, Piccart MJ, Castiglione M, Tu D, Shepherd LE, Pritchard KI, Livingston RB, Davidson NE, Norton L, Perez EA, Abrams JS, Cameron DA, Palmer MJ, Pater JL (2005) J Natl Cancer Inst 97:1262
Goss PE, Bondarenko IN, Manikhas GN, Pendergrass KB, Miller WH (2006) J Clin Oncol 24:525
Henderson D, Norbisrath G, Kerb U (1986) J Steroid Biochem 24:303
Berry J (2005) Clin Ther 27:1671
Miller WR, Anderson TJ, White S, Larionov A, Murray J, Evans D, Krause A, Dixon JM (2005) J Steroid Biochem Mol Biol 95:83
Lönning PE, Taylor PD, Anker G (2001) Breast Cancer Res Treat 67:111
Brodie AM, Lu Q, Long BJ, Fulton A, Chen T, Macpherson N, DeJong PC, Blankenstein MA, Nortier JW, Slee PH, van de Ven J, van Gorp JM, Elbers JR, Schipper ME, Blijham GH, Thijssen JH (2001) J Steroid Biochem Mol Biol 79:41
Osborne CK, Arteaga CL (2003) J Clin Oncol 21:285
Luu-The V (2001) Steroid Biochem Mol Biol 76:143
Poirier D (2003) Curr Med Chem 10:453
Tremblay MR, Poirier D (1998) J Steroid Biochem Molec Biol 66:179
Pasqualini JR, Chetrite GS (2005) J Steroid Biochem Mol Biol 93:221
Allan GM, Lawrence HR, Cornet J, Bubert C, Fischer DS, Vicker N, Smith A, Tutill HJ, Purohit A, Day JM, Mahon MF, Reed MJ, Potter BV (2006) J Med Chem 49:1325
Luu-The V, Zhang Y, Poirier D, Labrie F (1995) J Steroid Biochem Mol Biol 55:581
Santner SJ, Santen RJ (1993) J Steroid Biochem Mol Biol 45:383
Poutanen M, Moncharmont B, Vihko R (1992) Cancer Res 52:290
Reed MJ, Purohit A, Woo LW, Newman SP, Potter BV (2005) Endocr Rev 26:171
Suzuki T, Miki Y, Nakamura Y, Moriya T, Ito K, Ohuchi N, Sasano H (2005) Endocr Relat Cancer 12:701
Ahmed S, James K, Owen CP (2002) J Steroid Biochem Mol Biol 82:425
Zhu BT, Fu JH, Xu S, Kauffman FC, Conney AH (1998) Biochem Biophys Res Commun 246:45
Woo LW, Howarth NM, Purohit A, Hejaz HA, Reed MJ, Potter BV (1998) J Med Chem 41:1068
Winum JY, Scozzafava A, Montero JL, Supuran CT (2005) Med Res Rev 25:186
Ahmed S, James K, Owen CP, Patel CK, Patel MB (2001) Bioorg Med Chem Lett 11:3001
Ahmed S, Owen CP, James K, Sampson L, Patel CK (2002) Curr Med Chem 9:263
Walter G, Liebl R, von Angerer E (2004) Arch Pharm (Weinheim) 337:634
Shields-Botella J, Bonnet P, Duc I, Duranti E, Meschi S, Cardinali S, Prouheze P, Chaigneau AM, Duranti V, Gribaudo S, Riviere A, Mengual L, Carniato D, Cecchet L, Lafay J, Rondot B, Sandri J, Pascal JC, Delansorne R (2003) J Steroid Biochem Mol Biol 84:327
Woo LW, Sutcliffe OB, Bubert C, Grasso A, Chander SK, Purohit A, Reed MJ, Potter BV (2003) J Med Chem 46:3193
Russell DW, Wilson JD (1994) Annu Rev Biochem 63:25
Steers WD (2001) Urology 58:17
Katz MD, Cai LQ, Zhu YS, Herrera C, DeFillo-Ricart M, Shackleton CH, Imperato-McGinley J (1995) J Clin Endocrinol Metab 80:3160
Gerst C, Dalko M, Pichaud P, Galey JB, Buan B, Bernard BA (2002) Exp Dermatol 11:52
Bratoeff E, Cabeza M, Ramirez E, Heuze Y, Flores E (2005) Curr Med Chem 12:927
Frye SV (2006) Curr Top Med Chem 6:405
Ranjan M, Diffley P, Stephen G, Price D, Walton TJ, Newton RP (2002) Life Sci 71:115
Occhiato EG, Guarna A, Danza G, Serio M (2004) J Steroid Biochem Mol Biol 88:1
Hirsch KS, Jones CD, Audia JE, Andersson S, McQuaid L, Stamm NB, Neubauer BL, Pennington P, Toomey RE, Russell DW (1993) Proc Natl Acad Sci USA 90:5277
Ferrali A, Menchi G, Occhiato EG, Danza G, Mancina R, Serio M, Guarna A (2005) Bioorg Med Chem Lett 15:145
Occhiato EG, Ferrali A, Menchi G, Guarna A, Danza G, Comerci A, Mancina R, Serio M, Garotta G, Cavalli A, De Vivo M, Recanatini M (2004) J Med Chem 47:3546
Salem OI, Frotscher M, Scherer C, Neugebauer A, Biemel K, Streiber M, Maas R, Hartmann RW (2006) J Med Chem 49:748
Ishibashi K, Nakajima K, Sugioka Y, Sugiyama M, Hamada T, Horikoshi H, Nishi T (1999) Chem Pharm Bull 47:226
Fukuta Y, Fukuda Y, Higashino R, Yoshida K, Ogishima M, Tamaki H, Takei M (1999) J Pharmacol Exp Ther 290:1013
Tarter TH, Vaughan ED Jr (2006) Curr Pharm Des 12:775
Marks LS, Partin AW, Epstein JI, Tyler VE, Simon I, Macairan ML, Chan TL, Dorey FJ, Garris JB, Veltri RW, Santos PB, Stonebrook KA, deKernion JB (2000) J Urol 163:1451
Foley CL, Kirby RS (2003) Curr Opin Urol 13:31
Djavan B, Milani S, Fong YK (2005) Expert Opin Pharmacother 6:311
Roehrborn CG, Lukkarinen O, Mark S, Siami P, Ramsdell J, Zinner N (2005) BJU Int 96:572
Thomas LN, Lazier CB, Gupta R, Norman RW, Troyer DA, O'Brien SP, Rittmaster RS (2005) Prostate 63:231
Iczkowski KA, Qiu J, Qian J, Somerville MC, Rittmaster RS, Andriole GL, Bostwick DG (2005) Urology 65:76
Gomella LG (2005) Curr Opin Urol 15:29
Leroux F (2005) Curr Med Chem 12:1623
Barrie SE, Haynes BP, Potter GA, Chan FC, Goddard PM, Dowsett M, Jarman M (1997) J Steroid Biochem Mol Biol 60:347
Njar VC, Brodie AM (1999) Curr Pharm Des 3:163
Haidar S, Ehmer PB, Barassin S, Batzl-Hartmann C, Hartmann RW (2003) J Steroid Biochem Mol Biol 84:555
Hartmann RW, Palusczak A, Lacan F, Ricci G, Ruzziconi R (2004) J Enzyme Inhib Med Chem 19:145
Fisher B (1999) Eur J Cancer 35:1963
Levenson AS, Jordan VC (1999) Eur J Cancer 35:1974
Robertson JF (2004) Cancer Treat Rev 30:695
Cauley JA, Norton L, Lippman ME, Eckert S, Krueger KA, Purdie DW, Farrerons J, Karasik A, Mellstrom D, Ng KW, Stepan JJ, Powles TJ, Morrow M, Costa A, Silfen SL, Walls EL, Schmitt H, Muchmore DB, Jordan VC, Ste-Marie LG (2001) Breast Cancer Res Treat 65:125
Sommer S, Fuqua SA (2001) Semin Cancer Biol 11:339
Wakeling AE, Dukes M, Bowler J (1991) Cancer Res 51:3867
Bohlmann R, Bittler D, Fritzemeier KH, Heinrich N, Hoffmann J, Hofmeister H, Künzer H. Lessl, Lichtner R, Nishino Y, Parczyk K, Sauer G, Schneider MR (2001) Cancer Res Clin Oncol 127:42
Hoffmann J, Bohlmann R, Heinrich N, Hofmeister H, Kroll J, Kunzer H, Lichtner RB, Nishino Y, Parczyk K, Sauer G, Gieschen H, Ulbrich HF, Schneider MR (2004) J Natl Cancer Inst 96:210
Jordan VC (2003) J Med Chem 46:883
Munster PN (2006) Expert Opin Investig Drugs 15:317
Gennari L (2005) Curr Opin Investig Drugs 6:1067
Gauthier S, Caron B, Cloutier J, Dory YL, Favre A, Larouche D, Mailhot J, Ouellet C, Schwerdtfeger A, Leblanc G, Martel C, Simard J, Merand Y, Belanger A, Labrie C, Labrie F (1997) J Med Chem 40:2117
Labrie F, Labrie C, Belanger A, Simard J, Giguere V, Tremblay A, Tremblay G (2001) J Steroid Biochem Mol Biol 79:213
Willson TM, Norris JD, Wagner BL, Asplin I, Baer P, Brown HR, Jones SA, Henke B, Sauls H, Wolfe S, Morris DC, McDonnell DP (1997) Endocrinology 138:3901
Wu YL, Yang X, Ren Z, McDonnell DP, Norris JD, Willson TM, Greene GL (2005) Mol Cell 18:413
Komm BS, Kharode YP, Bodine PV, Harris HA, Miller CP, Lyttle CR (2005) Endocrinology 146:3999
Buzdar AU (2005) Clin Cancer Res 11:906
Vogel CL (1998) Oncology (Williston Park) 12:9
Holli K (2002) Eur J Cancer 38:37
Marttunen MB, Hietanen P, Tiitinen A, Ylikorkala O (1998) J Clin Endocrinol Metab 83:1158
Buzdar A, Hayes D, El-Khoudary A, Yan S, Lonning P, Lichinitser M, Gopal R, Falkson G, Pritchard K, Lipton A, Wolter K, Lee A, Fly K, Chew R, Alderdice M, Burke K, Eisenber P (2002) Breast Cancer Res Treat 73:161
Albertazzi P, Sharma S (2005) Climacteric 8:214
Martino S, Cauley JA, Barrett-Connor E, Powles TJ, Mershon J, Disch D, Secrest RJ, Cummings SR (2004) J Natl Cancer Inst 96:1751
Vogel VG, Costantino JP, Wickerham DL, Cronin WM, Cecchini RS, Atkins JN, Bevers TB, Fehrenbacher L, Pajon ER Jr, Wade JL III, Robidoux A, Margolese RG, James J, Lippman SM, Runowicz CD, Ganz PA, Reis SE, McCaskill-Stevens W, Ford LG, Jordan VC, Wolmark N (2006) JAMA 295:2727
Gruber C, Gruber D (2004) Curr Opin Investig Drugs 5:1086
Kelloff GJ, Lippman SM, Dannenberg AJ, Sigman CC, Pearce HL, Reid BJ, Szabo E, Jordan VC, Spitz MR, Mills GB, Papadimitrakopoulou VA, Lotan R, Aggarwal BB, Bresalier RS, Kim J, Arun B, Lu KH, Thomas ME, Rhodes HE, Brewer MA, Follen M, Shin DM, Parnes HL, Siegfried JM, Evans AA, Blot WJ, Chow WH, Blount PL, Maley CC, Wang KK, Lam S, Lee JJ, Dubinett SM, Engstrom PF, Meyskens FL Jr, O'Shaughnessy J, Hawk ET, Levin B, Nelson WG, Hong WK (2006) Clin Cancer Res 12:3661
Sato M, Turner CH, Wang T, Adrian MD, Rowley E, Bryant HU (1998) J Pharmacol Exp Ther 287:1
Fabian CJ, Kimler BF, Anderson J, Tawfik OW, Mayo MS, Burak WE Jr, O'Shaughnessy JA, Albain KS, Hyams DM, Budd GT, Ganz PA, Sauter ER, Beenken SW, Grizzle WE, Fruehauf JP, Arneson DW, Bacus JW, Lagios MD, Johnson KA, Browne D (2004) Clin Cancer Res 10:5403
Labrie F, Champagne P, Labrie C, Roy J, Laverdiere J, Provencher L, Potvin M, Drolet Y, Pollak M, Panasci L, L'Esperance B, Dufresne J, Latreille J, Robert J, Samson B, Jolivet J, Yelle L, Cusan L, Diamond P, Candas B (2004) J Clin Oncol 22:864
Wakeling AE (1993) J Steroid Biochem Mol Biol 47:107
Wijayaratne AL, McDonnell DP (2001) J Biol Chem 276:35684
Howell A, Pippen J, Elledge RM, Mauriac L, Vergote I, Jones SE, Come SE, Osborne CK, Robertson JF (2005) Cancer 104:236
Robertson JF, Come SE, Jones SE, Beex L, Kaufmann M, Makris A, Nortier JW, Possinger K, Rutqvist LE (2005) Eur J Cancer 41:346
Ismail PM, Amato P, Soyal SM, DeMayo FJ, Conneely OM, O'Malley BW, Lydon JP (2003) Steroids 68:779
Parczyk K, Schneider MR (1996) J Cancer Res Clin Oncol 122:383
Michna H, Nishino Y, Neef G, McGuire WL, Schneider MR (1992) J Steroid Biochem Mol Biol 41:339
Brisken C, Park S, Vass T, Lydon JP, O'Malley BW, Weinberg RA (1998) Proc Natl Acad Sci USA 95:5076
Lydon JP, Ge G, Kittrell FS, Medina D, O'Malley BW (1999) Cancer Res 59:4276
Chwalisz K, Perez MC, Demanno D, Winkel C, Schubert G, Elger W (2005) Endocr Rev 26:423
Belanger A, Philibert D, Teutsch G (1981) Steroids 37:361
Klijn JGM, Setyono-Han B, Foekens JA (2000) Steroids 65:825
Elger W, Bartley J, Schneider B, Kaufmann G, Schubert G, Chwalisz K (2000) Steroids 65:713
Fuhrmann U, Hess-Stumpp H, Cleve A, Neef G, Schwede W, Hoffmann J, Fritzemeier KH, Chwalisz K (2000) J Med Chem 43:5010
Negro-Vilar A (2000) J Soc Gynecol Investig 7:53
Allan GF, Sui Z (2005) Mini Rev Med Chem 5:701
Terefenko EA, Kern J, Fensome A, Wrobel J, Zhu Y, Cohen J, Winneker R, Zhang Z, Zhang P (2005) Bioorg Med Chem Lett 15:3600
Schneider MR, Michna H, Nishino Y, el Etreby MF (1989) Eur J Cancer Clin Oncol 25:691
Hoffmann J, Lichtner RB, Fuhrmann U, Michna H, Parczyk K, Neef G, Chwalisz K, Schneider MR (2002) Effects of Progesterone Receptor Antagonists on Breast Cancer. In: Robertson JFR, Nicholson RI, Hayes DF (eds) Endocrine Management of Breast Cancer. Dunitz
Hoffmann J, Sommer A (2005) J Steroid Biochem Mol Biol 93:191
Michna H, Gehring S, Kuhnel W, Nishino Y, Schneider MR (1992) J Steroid Biochem Mol Biol 43:203
Klijn JG, Setyono-Han B, Sander HJ, Lamberts SW, de Jong FH, Deckers GH, Foekens JA (1994) Hum Reprod 9:181
Jonat W, Giurescu M, Robertson JFR (2002) The Clinical Efficacy of Progesterone Antagonists in Breast Cancer. In: Robertson JFR, Nicholson RI, Hayes DF (eds) Endocrine Management of Breast Cancer. Martin Dunitz Ltd, London
Robertson JF, Willsher PC, Winterbottom L, Blamey RW, Thorpe S (1999) Eur J Cancer 35:214
El Etreby MF, Liang Y (1998) Breast Cancer Res Treat 49:109
Chwalisz K, Perez MC, Demanno D, Winkel C, Schubert G, Elger W (2005) Endocr Rev 26:423
Chabbert-Buffet N, Meduri G, Bouchard P, Spitz IM (2005) Hum Reprod Update 11:293
Anderson J (2003) BJU Int 91:455
Visakorpi T, Hyytinen E, Koivisto P, Tanner M, Keinanen R, Palmberg C, Palotie A, Tammela T, Isola J, Kallioniemi OP (1995) Nat Genet 9:401
Zhao XY, Malloy PJ, Krishnan AV, Swami S, Navone NM, Peehl DM, Feldman D (2000) Nat Med 6:703
Culig Z, Hobisch A, Cronauer MV, Radmayr C, Trapman J, Hittmair A, Bartsch G, Klocker H (1994) Cancer Res 54:5474
Culig Z, Bartsch G, Hobisch A (2004) Curr Cancer Drug Target 4:455
Neumann F (1994) Exp Clin Endocrinol 102:1
Gao W, Bohl CE, Dalton JT (2005) Chem Rev 105:3352
Salvati ME, Balog A, Wei DD, Pickering D, Attar RM, Geng J, Rizzo CA, Hunt JT, Gottardis MM, Weinmann R, Martinez R (2005) Bioorg Med Chem Lett 15:389
Bohl CE, Chang C, Mohler ML, Chen J, Miller DD, Swaan PW, Dalton JT (2004) J Med Chem 47:3765
Gao W, Reiser PJ, Coss CC, Phelps MA, Kearbey JD, Miller DD, Dalton JT (2005) Endocrinology 146:4887
Bohl CE, Miller DD, Chen J, Bell CE, Dalton JT (2005) J Biol Chem 280:37747
Furr BJ, Tucker H (1996) Urology 47:13
Tyrrell CJ, Denis L, Newling D, Soloway M, Channer K, Cockshott ID (1998) Eur Urol 33:39
Tyrrell CJ, Kaisary AV, Iversen P, Anderson JB, Baert L, Tammela T, Chamberlain M, Webster A, Blackledge G (1998) Eur Urol 33:447
Iversen P, Tyrrell CJ, Kaisary AV, Anderson JB, Van Poppel H, Tammela TL, Chamberlain M, Carroll K, Melezinek I (2000) J Urol 164:1579
Denis L (1994) Prostate 5:17
Denis LJ, Keuppens F, Smith PH, Whelan P, de Moura JL, Newling D, Bono A, Sylvester R (1998) Eur Urol 33:144
Eisenberger MA, Blumenstein BA, Crawford ED, Miller G, McLeod DG, Loehrer PJ, Wilding G, Sears K, Culkin DJ, Thompson IM Jr, Bueschen AJ, Lowe BA (1998) N Engl J Med 339:1036
Schmitt B, Wilt TJ, Schellhammer PF, DeMasi V, Sartor O, Crawford ED, Bennett CL (2001) Urology 57:727
Leibowitz RL, Tucker SJ (2001) Oncologist 6:177
Dawson NA (2000) Curr Oncol Rep 2:409
Grossfeld GD, Chaudhary UB, Reese DM, Carroll PR, Small EJ (2001) Urology 58:240
Mcleod DG (2002) Urology 60:13
Eder IE, Hoffmann J, Rogatsch H, Schafer G, Zopf D, Bartsch G, Klocker H (2002) Cancer Gene Ther 9:117
Ingle JN (2002) Breast Cancer Res 4:133
Mabjeesh NJ, Escuin D, LaVallee TM, Pribluda VS, Swartz GM, Johnson MS, Willard MT, Zhong H, Simons JW, Giannakakou P (2003) Cancer Cell 3:363
Pasqualini JR, Ebert C, Chetrite GS (2001) Gynecol Endocrinol 6:44
Lundgren S, Helle SI, Lonning PE (1996) Clin Cancer Res 2:1515
Schally AV (1999) Peptides 20:1247
Florio S, Pagnini U, Crispino A, Pacilio C, Crispino L, Giordano A (2002) Front Biosci 7:1590
Beckers T, Reilander H, Hilgard P (1997) Anal Biochem 251:17
Hovelmann S, Hoffmann SH, Kuhne R, ter Laak T, Reilander H, Beckers T (2002) Biochemistry 41:1129
Kiesel LA, Rody A, Greb RR, Szilagyi A (2002) Clin Endocrinol (Oxf) 56:677
Schally AV, Halmos G, Rekasi Z, Arencibia JM (2001) The actions of LH-RH agonists, antagonists, and cytotoxic analogs on the LH-RH receptors on the pituitary and tumors. In: Devroey P (ed) Infertility and reproductive medicine clinics of North America. Saunders, Philadelphia, pp 12, 17–44
Pinsky J, Lamharzi N, Halmos G, Groot K, Jungwirth A, Vadillo-Buenfil M, Kakar SS, Schally AV (1996) Endocrinology 137:3430
Schally AV, Comaru-Schally AM, Plonowski A, Nagy A, Halmos G, Rekasi Z (2000) The Prostate 45:158
Denmeade SR, Isaacs JT (2002) Nat Rev Cancer 2:389
Gonzalez-Barcena D, Vadillo Buenfil M, Garcia Procel E, Guerra-Arguero L, Cardenas Cornejo I, Comaru-Schally AM, Schally AV (1994) Eur J Endocrinol 131:286
Jonat W (2002) Eur J Cancer 38:39
Robertson JF, Blamey RW (2003) Eur J Cancer 39:861
Emons G, Schulz KD (2000) Rec Res Cancer Res 153:83
Asbury RF, Brunetto VL, Lee RB, Reid G, Rocereto TF (2002) Am J Clin Oncol 25(6):557
Hall JM, McDonnell DP (2005) Mol Interv 5:343
Author information
Authors and Affiliations
Corresponding author
Editor information
Rights and permissions
Copyright information
© 2006 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Hoffmann, J., Sommer, A. (2006). Anti-hormone Therapy: Principles of Endocrine Therapy of Cancer. In: Bradbury, R.H. (eds) Cancer. Topics in Medicinal Chemistry, vol 1. Springer, Berlin, Heidelberg. https://doi.org/10.1007/7355_2006_002
Download citation
DOI: https://doi.org/10.1007/7355_2006_002
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-33119-3
Online ISBN: 978-3-540-33120-9
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)